Erratum: Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Letizia Amadori^#^{1

2}, Claudia Calcagno^#^{3

4}, Dawn M Fernandez⁵, Simon Koplev⁶, Nicolas Fernandez⁶, Ravneet Kaur¹, Pauline Mury⁵, Nayaab S Khan⁵, Swathy Sajja¹, Roza Shamailova¹, Yannick Cyr¹, Minji Jeon⁶, Christopher A Hill⁵, Peik Sean Chong², Sonum Naidu^{3

4}, Ken Sakurai^{3

4}, Adam Ali Ghotbi^{3

4}, Raphael Soler^{3

4}, Natalia Eberhardt¹, Adeeb Rahman^{2

7}, Peter Faries⁸, Kathryn J Moore¹, Zahi A Fayad^{3

4}, Avi Ma'ayan⁶, Chiara Giannarelli^{1

5

9}

Affiliations

¹ Department of Medicine, Division of Cardiology, NYU Cardiovascular Research Center, New York, NY USA.
² The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
³ BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁴ Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁵ Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁶ Mount Sinai Center for Bioinformatics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁷ Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁸ Department of Surgery, Vascular Division, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁹ Department of Pathology; NYU Grossman School of Medicine, NYU Langone Health, New York, NY USA.

^# Contributed equally.

Published Erratum

Letizia Amadori et al. Nat Cardiovasc Res. 2023.

. 2023;2(8):793.

doi: 10.1038/s44161-023-00310-1. Epub 2023 Jul 4.

¹ Department of Medicine, Division of Cardiology, NYU Cardiovascular Research Center, New York, NY USA.
² The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
³ BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁴ Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁵ Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁶ Mount Sinai Center for Bioinformatics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁷ Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁸ Department of Surgery, Vascular Division, Icahn School of Medicine at Mount Sinai, New York, NY USA.
⁹ Department of Pathology; NYU Grossman School of Medicine, NYU Langone Health, New York, NY USA.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.1038/s44161-023-00278-y.].

Keywords: Cardiology; Drug discovery; Dyslipidaemias; Immunotherapy; Systems analysis.

Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis.
Amadori L, Calcagno C, Fernandez DM, Koplev S, Fernandez N, Kaur R, Mury P, Khan NS, Sajja S, Shamailova R, Cyr Y, Jeon M, Hill CA, Chong PS, Naidu S, Sakurai K, Ghotbi AA, Soler R, Eberhardt N, Rahman A, Faries P, Moore KJ, Fayad ZA, Ma'ayan A, Giannarelli C. Amadori L, et al. Nat Cardiovasc Res. 2023 Jun;2(6):550-571. doi: 10.1038/s44161-023-00278-y. Epub 2023 Jun 8. Nat Cardiovasc Res. 2023. PMID: 37771373 Free PMC article.